3-[(2-CHLOROBENZYL)SULFANYL]-1H-1,2,4-TRIAZOL-5-YLAMINE
3-[(2-CHLOROBENZYL)SULFANYL]-1H-1,2,4-TRIAZOL-5-YLAMINE Basic information
- Product Name:
- 3-[(2-CHLOROBENZYL)SULFANYL]-1H-1,2,4-TRIAZOL-5-YLAMINE
- Synonyms:
-
- 3-[(2-CHLOROBENZYL)SULFANYL]-1H-1,2,4-TRIAZOL-5-YLAMINE
- 3-[(2-chlorobenzyl)sulfanyl]-1H-1,2,4-triazol-5-amine
- 5-{[(2-Chlorophenyl)methyl]sulfanyl}-4H-1,2,4-triazol-3-amine
- WAY-325282
- Antibacterial agent 117
- 1H-1,2,4-Triazol-3-amine, 5-[[(2-chlorophenyl)methyl]thio]-
- 3-((2-Chlorobenzyl)thio)-1H-1,2,4-triazol-5-amine
- CAS:
- 341944-06-7
- MF:
- C9H9ClN4S
- MW:
- 240.71
- Mol File:
- Mol File
More
Less
3-[(2-CHLOROBENZYL)SULFANYL]-1H-1,2,4-TRIAZOL-5-YLAMINE Chemical Properties
- Melting point:
- 142-144°C
- Boiling point:
- 488.6±47.0 °C(Predicted)
- Density
- 1.49±0.1 g/cm3(Predicted)
- storage temp.
- 4°C, protect from light
- solubility
- DMSO : 100 mg/mL (415.44 mM; Need ultrasonic)
- pka
- 9.73±0.40(Predicted)
- form
- Solid
- color
- White to off-white
More
Less
3-[(2-CHLOROBENZYL)SULFANYL]-1H-1,2,4-TRIAZOL-5-YLAMINE Usage And Synthesis
Uses
Antibacterial agent 117, triazole derivative, is an antibacterial agent. Antibacterial agent 117 has against R. prowazekii MetAP1 (RpMetAP1) activity with an IC50 value of 15 μM. Antibacterial agent 117 also inhibits rickettsial growth and can be used for the research of infection[1].
References
[1] Travis R Helgren, et al. Rickettsia prowazekii methionine aminopeptidase as a promising target for the development of antibacterial agents. Bioorg Med Chem DOI:10.1016/j.bmc.2016.11.013
3-[(2-CHLOROBENZYL)SULFANYL]-1H-1,2,4-TRIAZOL-5-YLAMINESupplier
Wuhan Chemwish Technology Co., Ltd
- Tel
- 86-027-67849912
- sales@chemwish.com
Shanghai YuanYe Biotechnology Co., Ltd.
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
Tianjin Kailiqi Biotechnology Co., Ltd.
- Tel
- 15076683720
- klq@cw-bio.com
Shanghai Haohong Pharmaceutical Co., Ltd.
- Tel
- 400-8210725 4008210725
- malulu@leyan.com
Bide Pharmatech Ltd.
- Tel
- 400-1647117 13681763483
- product02@bidepharm.com